West Pharmaceutical Services, Inc. (WST)
NYSE·Healthcare·Medical - Instruments & Supplies
$291.37
-3.54%
Mkt Cap $19.79B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 23, 2026 | $780.31M | $844.90M | +8.28% | $1.68 | $2.13 | +26.79% | — | — |
| Q1 2026 Feb 12, 2026 | $794.89M | $805.00M | +1.27% | $1.83 | $2.04 | +11.48% | — | — |
| Q4 2025 Oct 23, 2025 | $785.71M | $804.30M | +2.37% | $1.68 | $1.96 | +16.67% | — | — |
| Q3 2025 Jul 24, 2025 | $726.09M | $766.20M | +5.52% | $1.51 | $1.84 | +21.85% | — | — |
| Q2 2025 Apr 24, 2025 | $712.98M | $698.00M | -2.10% | $1.22 | $1.45 | +18.85% | — | — |
| Q1 2025 Feb 13, 2025 | $740.47M | $748.80M | +1.12% | $1.71 | $1.82 | +6.43% | — | — |
| Q4 2024 Oct 24, 2024 | $709.62M | $746.90M | +5.25% | $1.50 | $1.85 | +23.33% | — | — |
| Q3 2024 Jul 25, 2024 | $729.36M | $702.00M | -3.75% | $1.74 | $1.52 | -12.64% | — | — |
| Q2 2024 Apr 25, 2024 | $670.62M | $695.40M | +3.69% | $1.26 | $1.56 | +23.81% | — | — |
| Q1 2024 Feb 15, 2024 | $739.47M | $732.00M | -1.01% | $1.78 | $1.83 | +2.81% | — | — |
| Q4 2023 Oct 26, 2023 | $750.31M | $747.40M | -0.39% | $1.86 | $2.16 | +16.13% | — | — |
| Q3 2023 Jul 27, 2023 | $756.53M | $753.80M | -0.36% | $1.93 | $2.11 | +9.33% | — | — |
| Q2 2023 Apr 27, 2023 | $698.19M | $716.60M | +2.64% | $1.67 | $1.98 | +18.56% | — | — |
| Q1 2023 Feb 16, 2023 | $657.17M | $708.70M | +7.84% | $1.38 | $1.77 | +28.26% | — | — |
| Q4 2022 Oct 27, 2022 | $727.42M | $686.90M | -5.57% | $2.12 | $2.03 | -4.25% | — | — |
| Q3 2022 Jul 28, 2022 | $754.25M | $771.30M | +2.26% | $2.21 | $2.47 | +11.76% | — | — |
| Q2 2022 Apr 28, 2022 | $720.92M | $720.00M | -0.13% | $2.12 | $2.30 | +8.49% | — | — |
| Q1 2022 Feb 17, 2022 | $710.20M | $730.80M | +2.90% | $1.92 | $2.04 | +6.25% | — | — |
| Q4 2021 Oct 28, 2021 | $687.09M | $706.50M | +2.82% | $1.80 | $2.06 | +14.44% | — | — |
| Q3 2021 Jul 29, 2021 | $669.38M | $723.60M | +8.10% | $1.74 | $2.46 | +41.38% | — | — |